| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0928-0197(98)00016-6 |
| P953 | full work available online at | https://api.elsevier.com/content/article/PII:S0928019798000166?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S0928019798000166?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 9646000 |
| P2093 | author name string | R. L. Hodinka | |
| P2860 | cites work | Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion | Q72624142 |
| Comparison of the Chiron Quantiplex branched DNA (bDNA) assay and the Abbott Genostics solution hybridization assay for quantification of hepatitis B viral DNA | Q73068634 | ||
| Comparison of branched DNA and reverse transcriptase polymerase chain reaction for quantifying six different HIV-1 subtypes in plasma | Q95824259 | ||
| High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR | Q22242246 | ||
| A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml | Q24545015 | ||
| Preclinical evaluation of AMPLICOR hepatitis C virus test for detection of hepatitis C virus RNA | Q27485655 | ||
| Evaluation of automated COBAS AMPLICOR PCR system for detection of several infectious agents and its impact on laboratory management | Q27485764 | ||
| Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method | Q27485773 | ||
| NASBATM isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection | Q28285678 | ||
| Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection | Q29547852 | ||
| Viral dynamics in human immunodeficiency virus type 1 infection | Q29547908 | ||
| Rapid and simple method for purification of nucleic acids | Q29615124 | ||
| Prognosis in HIV-1 infection predicted by the quantity of virus in plasma | Q29619980 | ||
| The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team | Q34063280 | ||
| Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. | Q34427085 | ||
| Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group | Q34736939 | ||
| Hepatitis B virus. New and evolving issues | Q35224757 | ||
| Direct detection of cytomegalovirus in peripheral blood leukocytes--a review of the antigenemia assay and polymerase chain reaction | Q35231312 | ||
| CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review | Q35250092 | ||
| Quantitative or semi-quantitative PCR: reality versus myth | Q35663046 | ||
| Activation of virus replication after vaccination of HIV-1-infected individuals. | Q36365672 | ||
| Quantitation of human immunodeficiency virus type 1 DNA and RNA by a novel internally controlled PCR assay | Q36523010 | ||
| Rapid and Precise Quantification of HIV-1 RNA in Plasma Using a Branched DNA Signal Amplification Assay | Q46131541 | ||
| Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay. | Q46171706 | ||
| Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction. | Q46429982 | ||
| Comparison of four methods for quantitative measurement of hepatitis B viral DNA. | Q52889636 | ||
| Quantification of HIV-1 RNA in Plasma: Comparable Results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV Monitor Test | Q56778615 | ||
| Clinical Evaluation of Branched DNA Signal Amplification for Quantifying HIV Type 1 in Human Plasma | Q57998141 | ||
| Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients | Q67849608 | ||
| Competitive polymerase chain reaction assay for quantitation of HIV-1 DNA and RNA | Q67878723 | ||
| Effect of CD4+ cell count measurement variability on staging HIV-1 infection | Q67885079 | ||
| HIV-1 viral DNA load in peripheral blood mononuclear cells from seroconverters and long-term infected individuals | Q68016886 | ||
| Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia | Q68248914 | ||
| Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia | Q68469036 | ||
| A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group | Q68524263 | ||
| Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B | Q70030183 | ||
| The long persistence of CMV DNA in the blood of renal transplant patients after recovery from CMV infection | Q70465901 | ||
| Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species | Q70540344 | ||
| Correlation of HBeAg/anti-HBe, ALT levels, and HBV DNA PCR results in HBsAg-positive patients | Q70712093 | ||
| To treat or not to treat? The judicious use of interferon-alpha-2a for the treatment of chronic hepatitis B | Q70756311 | ||
| A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection | Q71523437 | ||
| Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party | Q71523552 | ||
| Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay | Q71774797 | ||
| Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplification | Q72371315 | ||
| Use of competitive polymerase chain reaction to determine HIV-1 levels in response to antiviral treatments | Q72371323 | ||
| Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease | Q43049022 | ||
| Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. | Q43049490 | ||
| Plasma viremia in human immunodeficiency virus infection | Q43513599 | ||
| A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes | Q43626837 | ||
| Quantification of human cytomegalovirus DNA using the polymerase chain reaction | Q43984450 | ||
| Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group | Q44142380 | ||
| Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. | Q44192276 | ||
| Development and validation of a polymerase chain reaction method for the precise quantitation of HIV-1 DNA in blood cells from subjects undergoing a 1-year immunotherapeutic treatment | Q44540171 | ||
| Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus | Q44658783 | ||
| A Pilot Study to Evaluate the Development of Resistance to Nevirapine in Asymptomatic Human Immunodeficiency Virus-Infected Patients with CD4 Cell Counts of >500/mm3 : AIDS Clinical Trials Group Protocol 208 | Q44767336 | ||
| Quantification of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes of immunocompromised patients by the polymerase chain reaction. | Q44978524 | ||
| Evaluation of Two Methods for Quantitation of Hepatitis C Virus RNA. | Q45747602 | ||
| Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection | Q45763339 | ||
| Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Workin | Q45767657 | ||
| Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team. | Q45767659 | ||
| Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons | Q45769733 | ||
| Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma | Q45782351 | ||
| The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? | Q45783098 | ||
| Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial | Q45784267 | ||
| Quantitation of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis. | Q45784950 | ||
| Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study | Q45787521 | ||
| Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers. | Q45798572 | ||
| Quantitation of human immunodeficiency virus type 1 in the blood of infected persons | Q45844274 | ||
| Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen | Q45849086 | ||
| Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction | Q45853034 | ||
| The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. | Q45853669 | ||
| Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leuckocytes from AIDS patients with human cytomegalovirus viraemia | Q45860941 | ||
| Quantitation of plasma human immunodeficiency virus type 1 RNA by competitive polymerase chain reaction | Q45866507 | ||
| Quantitation of human immunodeficiency virus provirus and circulating virus: relationship with immunologic parameters | Q45874772 | ||
| Quantitation of human cytomegalovirus (HCMV) DNA in cerebrospinal fluid by competitive PCR in AIDS patients with different HCMV central nervous system diseases. | Q45977944 | ||
| Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases | Q36523190 | ||
| Intermethod variation in detection of human papillomavirus DNA in cervical smears | Q36525380 | ||
| Application of a commercial kit for detection of PCR products to quantification of human immunodeficiency virus type 1 RNA and proviral DNA. | Q36527729 | ||
| Detection of viral DNA to evaluate outcome of antiviral treatment of patients with recurrent genital herpes | Q36528531 | ||
| Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories | Q36541331 | ||
| Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma | Q36542026 | ||
| An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. | Q36542226 | ||
| Quantitation of cytomegalovirus (CMV) DNA in leukocytes of human immunodeficiency virus-infected subjects with and without CMV disease by using PCR and the SHARP Signal Detection System | Q36543316 | ||
| Evaluation of a quantitative competitive PCR assay for measuring herpes simplex virus DNA content in genital tract secretions | Q36543353 | ||
| Evaluation of a quantitative plasma PCR plate assay for detecting cytomegalovirus infection in marrow transplant recipients. | Q36543781 | ||
| Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay | Q36547227 | ||
| Comparison of the Amplicor HIV-1 monitor test and the nucleic acid sequence-based amplification assay for quantitation of human immunodeficiency virus RNA in plasma, serum, and plasma subjected to freeze-thaw cycles | Q36548250 | ||
| Markers predicting progression of human immunodeficiency virus-related disease | Q36640801 | ||
| Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients. | Q37095025 | ||
| Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patients | Q37116756 | ||
| Quantitation of human immunodeficiency virus DNA by using the polymerase chain reaction | Q37189779 | ||
| Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses | Q38337642 | ||
| Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study | Q38477498 | ||
| Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment | Q39187208 | ||
| Quantitative assay of PCR-amplified hepatitis B virus DNA using a peroxidase-labelled DNA probe and enhanced chemiluminescence. | Q40011263 | ||
| A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: enhanced sensitivity | Q40024842 | ||
| Comparison of methods for detection of hepatitis B virus DNA. | Q40179952 | ||
| Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction | Q40186840 | ||
| Detection of cytomegalovirus (CMV) in granulocytes by polymerase chain reaction compared with the CMV antigen test | Q40186852 | ||
| Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction | Q40342944 | ||
| Quantitative PCR and RT-PCR in virology | Q40485248 | ||
| Viral infections in severely immunocompromised cancer patients | Q40594928 | ||
| Prospective study utilizing a quantitative polymerase chain reaction for detection of cytomegalovirus DNA in the blood of renal transplant patients | Q40722007 | ||
| The application of quantitative polymerase chain reaction to therapeutic monitoring | Q40742164 | ||
| Toward routine diagnosis of hepatitis B virus desoxyribonucleic acid | Q40781495 | ||
| HIV viral load markers in clinical practice | Q40993134 | ||
| Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. | Q41277179 | ||
| Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel | Q41513115 | ||
| Correlation between HIV provirus burden and in utero transmission | Q41518688 | ||
| Measuring hepatitis C viremia in clinical samples: Can we trust the assays? | Q41523834 | ||
| Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates | Q41817594 | ||
| Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial | Q41839327 | ||
| A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group | Q42274436 | ||
| Comparison of quantitative HCV RNA assays in chronic hepatitis C. | Q42981669 | ||
| Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). | Q42984725 | ||
| Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C | Q42984730 | ||
| Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications | Q43037167 | ||
| Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C. | Q43041104 | ||
| Comparison of assays for HCV RNA. | Q43041122 | ||
| Interferon-alpha therapy for hepatitis C virus infection after liver transplantation | Q43041374 | ||
| Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial | Q43041441 | ||
| Serum hepatitis C virus RNA levels in chronic hepatitis C--importance for outcome of interferon alfa-2b treatment | Q43041553 | ||
| Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo | Q43046883 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nucleic acid amplification techniques | Q64737961 |
| P304 | page(s) | 25-47 | |
| P577 | publication date | 1998-05-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Clinical and diagnostic virology | Q27714224 |
| P1476 | title | The clinical utility of viral quantitation using molecular methods | |
| P478 | volume | 10 |
| Q42993471 | Comparison of the enzyme-linked immunosorbant assay III, recombinant immunoblot third generation assay, and polymerase chain reaction method in the detection of hepatitis C virus infection in haemodialysis patients |
| Q38779627 | Consolidation of molecular testing in clinical virology |
| Q35107691 | Cytomegalovirus infection in solid organ transplantation: economic implications |
| Q33762197 | Designing studies to confirm a link between viral infection and atherosclerosis |
| Q43765453 | Detection of hantavirus infection in hemolyzed mouse blood using alkaline phosphatase conjugate |
| Q34275907 | Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease |
| Q34306035 | Frontiers of polymerase chain reaction diagnostics for uveitis. |
| Q28364015 | Intra- and interlaboratory variabilities of results obtained with the Quantiplex human immunodeficiency virus type 1 RNA bDNA assay, version 3.0 |
| Q35067620 | Molecular analysis of cerebrospinal fluid in viral diseases of the central nervous system |
| Q36240147 | Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA) |
| Q40133351 | Multiplexed, real-time PCR for quantitative detection of human adenovirus |
| Q33812425 | New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients |
| Q33650397 | Prevention of transfusion-transmitted cytomegalovirus infection |
| Q37159312 | Principles and applications of polymerase chain reaction in medical diagnostic fields: a review |
| Q74097284 | Quantitation of polyomavirus DNA by a competitive nested polymerase chain reaction |
| Q33893071 | Quantitative molecular virology in patient management |
| Q40279797 | Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. |
| Q33893027 | Robotics into the millennium |
| Q43029585 | Strategy for the maximization of clinically relevant information from hepatitis C virus, RT-PCR quantification |
| Q38978220 | Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5' long terminal repeat domain |
Search more.